fda bpc-157 safety concerns compounding panel narrowly backs unapproved peptide drugs – NBC4 Washington FDA mulls compounding for peptides

My understandingbased on Dem-world hearsayis that the truth is stupider than the fiction: No autopsy was released because there is no actual autopsy

2) is a small, pea-shaped endocrine organ nestled deep within the epithalamus, between the two hemispheres of the brain, just above the midbrain tectum and behind the third ventricle

Takeaway: GHK-Cu is low-maintenance

Finally, for therapy effect of BPC 157 on paracetamol brain injury in rats that received pentadecapeptide BPC 157 later in an advanced paracetamol toxicity stage, we should consider that at the time point of 3 hours following paracetamol, as previously mentioned, after therapy these rats had initially exhibited generalized convulsions and had significant brain damage